cached image

Neil Dixon, PhD - Publications

Manchester Institute of Biotechnology University of Manchester, Manchester, England, United Kingdom 
Chemical biology, Medicinal chemistry and Synthetic Biology

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Muhamadali H, Xu Y, Morra R, Trivedi DK, Rattray NJ, Dixon N, Goodacre R. Metabolomic analysis of riboswitch containing E. coli recombinant expression system. Molecular Biosystems. PMID 26621574 DOI: 10.1039/c5mb00624d  0.44
2015 Morra R, Shankar J, Robinson CJ, Halliwell S, Butler L, Upton M, Hay S, Micklefield J, Dixon N. Dual transcriptional-translational cascade permits cellular level tuneable expression control. Nucleic Acids Research. PMID 26405200 DOI: 10.1093/nar/gkv912  0.44
2015 Wu MC, Lowe PT, Robinson CJ, Vincent HA, Dixon N, Leigh J, Micklefield J. Rational Re-engineering of a Transcriptional Silencing PreQ1 Riboswitch. Journal of the American Chemical Society. PMID 26106809 DOI: 10.1021/jacs.5b03405  0.44
2014 Vincent HA, Robinson CJ, Wu MC, Dixon N, Micklefield J. Generation of orthogonally selective bacterial riboswitches by targeted mutagenesis and in vivo screening. Methods in Molecular Biology (Clifton, N.J.). 1111: 107-29. PMID 24549615 DOI: 10.1007/978-1-62703-755-6_8  0.44
2012 Chen L, Cressina E, Dixon N, Erixon K, Agyei-Owusu K, Micklefield J, Smith AG, Abell C, Leeper FJ. Probing riboswitch-ligand interactions using thiamine pyrophosphate analogues. Organic & Biomolecular Chemistry. 10: 5924-31. PMID 22514012 DOI: 10.1039/c2ob07116a  0.44
2012 Dixon N, Robinson CJ, Geerlings T, Duncan JN, Drummond SP, Micklefield J. Orthogonal riboswitches for tuneable coexpression in bacteria. Angewandte Chemie (International Ed. in English). 51: 3620-4. PMID 22383398 DOI: 10.1002/anie.201109106  0.44
2011 Woolard J, Vousden W, Moss SJ, Krishnakumar A, Gammons MV, Nowak DG, Dixon N, Micklefield J, Spannhoff A, Bedford MT, Gregory MA, Martin CJ, Leadlay PF, Zhang MQ, Harper SJ, et al. Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chemical Science (Royal Society of Chemistry : 2010). 2011: 273-278. PMID 22822423 DOI: 10.1039/C0SC00297F  0.44
2011 Slade D, Dunstan MS, Barkauskaite E, Weston R, Lafite P, Dixon N, Ahel M, Leys D, Ahel I. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature. 477: 616-20. PMID 21892188 DOI: 10.1038/nature10404  0.44
2010 Dixon N, Duncan JN, Geerlings T, Dunstan MS, McCarthy JE, Leys D, Micklefield J. Reengineering orthogonally selective riboswitches. Proceedings of the National Academy of Sciences of the United States of America. 107: 2830-5. PMID 20133756 DOI: 10.1073/pnas.0911209107  0.44
2008 Kóta Z, Páli T, Dixon N, Kee TP, Harrison MA, Findlay JB, Finbow ME, Marsh D. Incorporation of transmembrane peptides from the vacuolar H(+)-ATPase in phospholipid membranes: spin-label electron paramagnetic resonance and polarized infrared spectroscopy. Biochemistry. 47: 3937-49. PMID 18307317 DOI: 10.1021/bi7025112  0.44
2008 Dixon N, Páli T, Kee TP, Ball S, Harrison MA, Findlay JB, Nyman J, Väänänen K, Finbow ME, Marsh D. Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector. Biophysical Journal. 94: 506-14. PMID 17872954 DOI: 10.1529/biophysj.107.111781  0.44
2007 Dixon N, Wong LS, Geerlings TH, Micklefield J. Cellular targets of natural products. Natural Product Reports. 24: 1288-310. PMID 18033580 DOI: 10.1039/b616808f  0.44
2006 Fernandes F, Loura LM, Fedorov A, Dixon N, Kee TP, Prieto M, Hemminga MA. Binding assays of inhibitors towards selected V-ATPase domains. Biochimica Et Biophysica Acta. 1758: 1777-86. PMID 16996024 DOI: 10.1016/j.bbamem.2006.07.006  0.44
2006 Fernandes F, Loura L, Koehorst RB, Dixon N, Kee TP, Hemminga MA, Prieto M. Interaction of the indole class of vacuolar H(+)-ATPase inhibitors with lipid bilayers. Biochemistry. 45: 5271-9. PMID 16618115 DOI: 10.1021/bi0522753  0.44
2005 Whyteside G, Meek PJ, Ball SK, Dixon N, Finbow ME, Kee TP, Findlay JB, Harrison MA. Concanamycin and indolyl pentadieneamide inhibitors of the vacuolar H+-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain. Biochemistry. 44: 15024-31. PMID 16274249 DOI: 10.1021/bi051529h  0.44
2004 Dixon N, Páli T, Kee TP, Marsh D. Spin-labelled vacuolar-ATPase inhibitors in lipid membranes. Biochimica Et Biophysica Acta. 1665: 177-83. PMID 15471583 DOI: 10.1016/j.bbamem.2004.08.001  0.44
2004 Páli T, Whyteside G, Dixon N, Kee TP, Ball S, Harrison MA, Findlay JB, Finbow ME, Marsh D. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector. Biochemistry. 43: 12297-305. PMID 15379568 DOI: 10.1021/bi0493867  0.44
2004 Páli T, Dixon N, Kee TP, Marsh D. Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies. Biochimica Et Biophysica Acta. 1663: 14-8. PMID 15157605 DOI: 10.1016/j.bbamem.2004.03.003  0.44
2003 Dixon N, Pali T, Ball S, Harrison MA, Marsh D, Findlay JB, Kee TP. New biophysical probes for structure-activity analyses of vacuolar-H+ -ATPase enzymes. Organic & Biomolecular Chemistry. 1: 4361-3. PMID 14685305 DOI: 10.1039/b311401e  0.44
2001 Pulacchini S, Shastri K, Dixon NC, Watkinson M. A remarkably efficient and direct route for the synthesis of binucleating 1,4,7-triazacyclononane ligands Synthesis. 2381-2383.  0.44
2001 Kee T, Dixon N. Living dangerously Chemistry in Britain. 37: 38-41.  0.44
Show low-probability matches.